The peer-authored management source for clinical lab professionals since 1969.
Continuing Education
Diagnostics
Disease
Management
Molecular
Sections
Continuing Education
Diagnostics
Disease
Management
Molecular
Information Technology
Online Exclusives
Special
Magazine
Newsletter
Webinars
White Papers
eBooks
Clinical Laboratory Reference
Videos
Events
Contact
About Us
Magazine Subscription
Newsletter Subscription
Advertise
Contact Us
Affiliated Brands
HEALTHCARE PURCHASING NEWS
HEALTHCARE INNOVATION
Follow us on
https://www.facebook.com/MLOMedicalLaboratoryObserver
https://www.linkedin.com/company/medical-laboratory-observer
https://twitter.com/MedicalLabMLO
Disease
ID 199955480 © Arne9001 | Dreamstime.com
STIs/STDs
Single sample simplicity for sexual health: The diagnostic journey of a single swab
Sexual health remains an essential pillar of care for all Americans. However, accessing timely testing is not always straightforward. For women and people with a cervix, access...
Dec. 22, 2025
ID 283644066 © Rafael Fores | Dreamstime.com
Cancer
Roche's Lunsumio VELO approved by FDA for subcutaneous use in R/R follicular lymphoma
Dec. 23, 2025
By angellodeco on Adobe Stock
Cancer
New diagnostic technology enhances glioblastoma therapy monitoring
Dec. 23, 2025
By ipopba on Adobe Stock
Disease
Rutgers-led trials demonstrate long-term success of less invasive heart procedures
Dec. 22, 2025
ID 55332634 © Kasto80 | Dreamstime.com
Infectious Disease
Ready or not: Operational readiness for HCID patients
Dec. 22, 2025
ID 173427039 © Steve Gergens | Dreamstime.com
Diabetes
The role of A1c and CGM testing
Dec. 22, 2025
ID 31124161 © Robert Kneschke | Dreamstime.com
STIs/STDs
New options for gonorrhea treatment: FDA approves Nuzolvence and Blujepa
Dec. 19, 2025
By Syda Productions on Adobe Stock
Disease
Teen substance use remains low but shows rising heroin and cocaine use
Dec. 18, 2025
ID 90301564 © Wave Break Media Ltd | Dreamstime.com
Diagnostics
Roche announces expanded FDA approval for first diagnostic tests to identify HER2-positive metastatic breast cancer patients eligible for ENHERTU
Dec. 17, 2025
Looking for Something?
Load More Content